订购/客服:400-623-8666 | 021-50706066
通过类别精选:
手性药用中间体
手性催化剂,配体和试剂
手性助剂
手性砌块
拆分试剂

COA查询:

例如:
批号:C10268951
货号:A800295-25g

在货品标签上如何找到货号和批号?
点击这里查看标签示例
产品编号 CAS号 项目名称规格 分子式 加入购物车
R854398 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
C49H31O4P
R854276 1801196-27-9 (11aR)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%,99%e.e.
(11aR)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%,99%e.e.
C35H35O4P
R854406 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C29H19Cl4O4P
R854259 1297613-75-2 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%,99%e.e.
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%,99%e.e.
C33H31O4P
R854402 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C31H21F6O4P
R854397 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C29H21Cl2O4P
R854404 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C31H27O6P
R854272 1352810-37-7 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,99%e.e.
(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,99%e.e.
C29H21N2O8P
R854274 1372719-94-2 (11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C53H43O4PSi2
R854265 1297613-77-4 (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C41H31O4P
R854275 1352810-38-8 (11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C53H39O4P
R854410 (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C47H59O6P
R854257 1297613-76-3 (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C33H19F12O4P
R854413 (11aR)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis[4-​(2-​naphthalenyl)​phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C49H35O4P
R906297 856407-37-9 (11aR)-5,6,10,11,12,13-六氢-5-苯基-4H-二茚并[7,1-cd:1',7'-ef]磷, 98%
(R)-Dimethylene-[7,7'-(1,1'-spiroindan)]-phenylphospholane, 98%
C25H23P
R967091 500997-67-1 (11aR)-N,N-二异丙基-4,5,6,7-四氢二茚并[7,1-de:1',7'-fg][1,3,2]二氧杂磷杂环辛-12-胺, 97%
(11aR)-N,N-Diisopropyl-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-12-amine, 97%
C23H28NO2P
R853901 443965-14-8 (11aR)​-10,​11,​12,​13-四氢-N,N-二甲基-​二吲哚并[7,​1-​de:1',​7'-​fg]​[1,​3,​2]​二氧膦杂-​5-​胺, ≥98%,≥99% e.e.
(11aR)-10,11,12,13-Tetrahydro-N,N-dimethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e.
C19H20NO2P
P906642 885701-71-3 (11AS)-(-)-10,11,12,13-四氢二茚并[7,1-DE:1′,7′-FG][1,3,2] 二氧磷杂八环-5-苯氧基 苯基-[(S)-1,1-螺二氢茚-7,7-二基]亚磷酸酯, 98%
Phenyl-[(S)-1,1-spirobiindane-7,7-diyl]-phosphite, 98%
C23H19O3P
S854412 (11aS)-)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aS)-)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C35H35O4P
S854409 (11aS)-)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aS)-)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C53H39O4P
首页|网站使用条款|隐私政策|关于我们|网站地图
Copyright © 2014 Macklin Inc. - All rights reserved. 沪ICP备14004368号-1

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。


沪公网安备 31011502007856号

危险品化学品经营许可证(带存储)

   
请填写购买数量! 您已收藏过此产品! 成功从购物车删除! 成功清楚购物车!